Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

0.0%

0 terminated/withdrawn out of 7 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

29%

2 trials in Phase 3/4

Results Transparency

0 of 2 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A

3(60.0%)

Phase 3

1(20.0%)

Phase 4

1(20.0%)

5Total

N/A(3)

Phase 3(1)

Phase 4(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (7)

Showing 7 of 7 trials

NCT06781918Phase 3Not Yet Recruiting

Severe Acute Malnutrition and Child Development Clinical Trial in Mwanza

Role: collaborator

NCT06376396Phase 4Not Yet Recruiting

Assessment of Combined Praziquantel and Albendazole vs Albendazole Alone to Treat Active Parenchymal Neurocysticercosis

Role: collaborator

NCT03834337Completed

Treatment of Patients With Active Neurocysticercosis in Eastern Africa

Role: collaborator

NCT04016012Not ApplicableUnknown

Overweight and Obesity in Relation to Type ll Diabetes Melitus

Role: collaborator

NCT05139524Unknown

RVF and Other Emerging Infectious Diseases in East and Central Africa

Role: collaborator

NCT03808597Not ApplicableCompleted

Digital Health Promotion in Iringa, Tanzania

Role: collaborator

NCT02249754Not ApplicableUnknown

Nutrition Education Package for Infants and Young Child Feeding and Health in Rural Tanzania

Role: lead

All 7 trials loaded